This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Recent findings that stem cells from a particular organ are capable of giving rise to mature tissues in other organs have changed our thinking about the role of stem cells in human disease and development. Bone marrow stem cells are among the most well characterized stem cells and they have been shown to be proficient in forming non-blood tissues. It is likely that bone marrow provides the cellular substrates for many organs and that bone marrow derived progenitors are recruited to areas of injury or wounds. There is evidence of this for the liver and heart. Understanding the dynamics of homing and recruitment of these bone marrow cells to the skin will be valuable in developing treatments for a variety of disorders. We have shown in preliminary studies that bone marrow cells can engraft into wounds and form skin structures. In a clinical study performed on human patients, we have evidence that bone marrow can accelerate healing and close chronic wounds that have failed to heal by other traditional and advanced treatments administered in specialized centers. The studies proposed will identify those bone marrow stem cells that home to skin and form skin structures. Purified bone marrow stem cells and whole bone marrow will be examined for their potential to engraft and reconstitute skin structures in wounded skin. The ability to utilize these adult stem cells may also allow us to avoid the use of unpredictable embryonic derived stem cells and may form the basis for all stem cell based treatments in the future.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR018757-04
Application #
7382032
Study Section
Special Emphasis Panel (ZRR1-RI-3 (01))
Project Start
2006-05-01
Project End
2007-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
4
Fiscal Year
2006
Total Cost
$210,864
Indirect Cost
Name
Roger Williams Hospital
Department
Type
DUNS #
625899281
City
Providence
State
RI
Country
United States
Zip Code
02908
Kim, Joseph W; Vang, Souriya; Luo, John Zq et al. (2017) Effects of bone marrow on the microenvironment of the human pancreatic islet: A Protein Profile Approach. Mol Cell Endocrinol 450:32-42
Luo, John Z Q; Kim, Joseph W; Luo, LuGuang (2016) EFFECTS OF GINSENG AND ITS FOUR PURIFED GINSENOSIDES (Rb2, Re, Rg1, Rd) ON HUMAN PANCREATIC ISLET ? CELL IN VITRO. Eur J Pharm Med Res 3:110-119
Tang, Jin Bo; Wu, Ya Fang; Cao, Yi et al. (2016) Basic FGF or VEGF gene therapy corrects insufficiency in the intrinsic healing capacity of tendons. Sci Rep 6:20643
Kim, Joseph W; Luo, John Z; Luo, Luguang (2015) The Biochemical Cascades of the Human Pancreatic ?-Cells: The Role of MicroRNAs. J Bioanal Biomed 7:
Luo, Lu Guang; Xiong, Fang; Ravassard, Philippe et al. (2015) Human Bone Marrow Subpopulations Sustain Human Islet Function and Viability In vitro. Br J Med Med Res 8:576-587
Ilgun, Handenur; Kim, Joseph William; Luo, LuGuang (2015) Adult Stem Cells and Diabetes Therapy. J Stem Cell Res Transplant 2:
Bartos, Adrian; Dubielecka, Patrycja M (2014) The emerging role of Bcr-Abl-induced cystoskeletal remodeling in systemic persistence of leukemic stem cells. Curr Drug Deliv 11:582-91
Chorzalska, A; Dubielecka, P M (2014) New Abelson interactor-1 (Abi-1)-driven mechanism of acquired drug resistance. Leuk Suppl 3:S7-8
Chorzalska, A; Salloum, I; Shafqat, H et al. (2014) Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia. Leukemia 28:2165-77
Dabiri, Ganary; Falanga, Vincent (2013) Connective tissue ulcers. J Tissue Viability 22:92-102

Showing the most recent 10 out of 90 publications